دورية أكاديمية

P1064: BRENTUXIMAB VEDOTIN, NIVOLUMAB, DOXORUBICIN, AND DACARBAZINE FOR ADVANCED STAGE CLASSICAL HODGKIN LYMPHOMA: UPDATED EFFICACY AND SAFETY RESULTS FROM THE SINGLE ARM PHASE 2 STUDY

التفاصيل البيبلوغرافية
العنوان: P1064: BRENTUXIMAB VEDOTIN, NIVOLUMAB, DOXORUBICIN, AND DACARBAZINE FOR ADVANCED STAGE CLASSICAL HODGKIN LYMPHOMA: UPDATED EFFICACY AND SAFETY RESULTS FROM THE SINGLE ARM PHASE 2 STUDY
المؤلفون: Yasenchak, Chris, Flinn, Ian W., Melear, Jason, Ramchandren, Rod, Friedman, Judah, Burke, John M., Linhares, Yuliya, Gonzales, Paul, Raval, Mihir, Chintapatla, Rangaswamy, Feldman, Tatyana A., Yimer, Habte, Islas-Ohlmayer, Miguel, Dean, Asad, Rana, Vishal, Gandhi, Mitul D., Renshaw, John, Ho, Linda, Fanale, Michelle, Guo, Wenchuan, Ju Lee, Hun
المصدر: HemaSphere ; volume 7, issue S3, page e5881312 ; ISSN 2572-9241
بيانات النشر: Wiley
سنة النشر: 2023
المجموعة: Wiley Online Library (Open Access Articles via Crossref)
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1097/01.hs9.0000971152.58813.12
DOI: 10.1097/01.HS9.0000971152.58813.12
الإتاحة: https://doi.org/10.1097/01.hs9.0000971152.58813.12Test
حقوق: http://creativecommons.org/licenses/by-nc-nd/4.0Test/
رقم الانضمام: edsbas.C6C398D7
قاعدة البيانات: BASE